Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

Anne-Sophie Chretien; Cyril Fauriat; Florence Orlanducci; Jerome Rey; Gaelle Bouvier Borg; Emmanuel Gautherot; Samuel Granjeaud; Clemence Demerle; Jean-François Hamel; Adelheid Cerwenka; Elke Pogge von Strandmann; Norbert Ifrah; Catherine Lacombe; Pascale Cornillet-Lefebvre; Jacques Delaunay; Antoine Toubert; Christine Arnoulet; Norbert Vey; Daniel Olive

doi:10.18632/oncotarget.27198

Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

Oncotarget. 2019 Sep 10;10(52):5493. doi: 10.18632/oncotarget.27198.

Authors

Anne-Sophie Chretien^{1

2}, Cyril Fauriat^{1

2}, Florence Orlanducci², Jerome Rey³, Gaelle Bouvier Borg⁴, Emmanuel Gautherot⁴, Samuel Granjeaud⁵, Clemence Demerle^{1

2}, Jean-François Hamel⁶, Adelheid Cerwenka⁷, Elke Pogge von Strandmann^{8

9}, Norbert Ifrah¹⁰, Catherine Lacombe¹¹, Pascale Cornillet-Lefebvre¹², Jacques Delaunay¹³, Antoine Toubert¹⁴, Christine Arnoulet^{1

15}, Norbert Vey^{1

3}, Daniel Olive^{1

2}

Affiliations

¹ Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.
² Immunomonitoring Platform, Institut Paoli-Calmettes, Marseille, France.
³ Hematology Department, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.
⁴ Beckman Coulter Immunotech, Marseille, France.
⁵ Systems Biology Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.
⁶ Biostatistics and Methodology Department, CHU Angers, Angers, France.
⁷ Innate Immunity Group, German Cancer Research Center, Heidelberg, Germany.
⁸ Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
⁹ Clinic for Hematology, Oncology and Immunology, Experimental Tumor Research, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.
¹⁰ Hematology Department, CHU Angers, Angers, France.
¹¹ GOELAMStheque, FILO French Innovative Leukemia Organization, Cochin Hospital, APHP, Paris, France.
¹² Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Reims, Reims, France.
¹³ Service d'Hématologie, Centre Catherine de Sienne, Nantes, France.
¹⁴ INSERM UMRS-1160, Univ Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Immunology and Histocompatibility Department, Hôpital Saint-Louis, APHP, Paris, France.
¹⁵ Biopathology Department, Institut Paoli Calmettes, Marseille, France.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.17747.].

Publication types

Published Erratum